COVID-19 associated with pulmonary aspergillosis: A literature review
Top Cited Papers
Open Access
- 1 February 2021
- journal article
- review article
- Published by Elsevier BV in Journal of Microbiology, Immunology and Infection
- Vol. 54 (1), 46-53
- https://doi.org/10.1016/j.jmii.2020.09.004
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Voriconazole associated torsades de pointes in two adult patients with haematological malignanciesMedical Mycology Case Reports, 2014
- Intensive Cytokine induction in Pandemic H1N1 Influenza Virus Infection Accompanied by Robust Production of IL-10 and IL-6PLOS ONE, 2011
- Interleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosisImmunology Letters, 2007
- General Framework for the Quantitative Prediction of CYP3A4-Mediated Oral Drug Interactions Based on the AUC Increase by Coadministration of??Standard DrugsClinical Pharmacokinetics, 2007
- Pulmonary pathology of severe acute respiratory syndrome in TorontoLaboratory Investigation, 2005
- Voriconazole-Induced QT Interval Prolongation and Ventricular Tachycardia: A Non--Concentration-Dependent Adverse EffectClinical Infectious Diseases, 2004
- No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteersBritish Journal of Clinical Pharmacology, 2003
- Lopinavir/RitonavirDrugs, 2003
- Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosisClinical and Experimental Immunology, 2000
- Antifungal type 1 responses are upregulated in IL-10-deficient miceMicrobes and Infection, 1999